Ipilimumab, a human monoclonal antibody for treatment of unresectable or metastatic melanoma
Wilkes, G.M.
Oncology 25(7 Suppl Nurse Ed): 46-47
2011
ISSN/ISBN: 0890-9091 PMID: 25373277 Document Number: 654304
Document emailed within 1 workday
Related Documents
Chattopadhyay, P.; Kaveri, S.V.; Byars, N.; Starkey, J.; Ferrone, S.; Raychaudhuri, S. 1991: Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1 Cancer Research 51(22): 6045-6051Matsui, M.; Temponi, M.; Ferrone, S. 1987: Characterization of a monoclonal antibody-defined human melanoma-associated antigen susceptible to induction by immune interferon Journal of Immunology 139(6): 2088-2095
Fukaya, T. 1991: Mouse monoclonal antibody (FKH1) detecting human melanoma-associated antigens: production, partial characterization and immunohistochemical analysis Hokkaido Journal of Medical Science 66(3): 300-310
Morgan, A.C.; McIntyre, R.F. 1983: Monoclonal antibodies to human melanoma-associated antigens: an amplified enzyme-linked immunosorbent assay for the detection of antigen, antibody, and immune complexes Cancer Research 43(7): 3155-3159
Kargi, A.; Yalcin, A.D.; Erin, N.; Savas, B.; H. Hüseyin Polat; Gorczynski, R.M. 2012: IL8 and Serum Soluble Trail Levels Following Anti-VEGF Monoclonal Antibody Treatment in Patients With Metastatic Colon Cancer Clinical Laboratory 58(5-6): 501-505
Temponi, M.; Gold, A.M.; Ferrone, S. 1992: Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen Cancer Research 52(9): 2497-2503
Murray, J.L.; Macey, D.J.; Grant, E.J.; Rosenblum, M.G.; Kasi, L.P.; Zhang, H.Z.; Katz, R.L.; Riger, P.T.; LeBherz, D.; Bhadkamkar, V. 1995: Enhanced TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatment Cancer Research 55(23 Suppl): 5925s-5928s
Oliver, J.L.; Wolfe, L.G.; Lopez, M.K.; Church-Bird, A.; Toivio-Kinnucan, M.; Dietrich, M.A. 1997: Isolation and characterization of the canine melanoma antigen recognized by the murine monoclonal antibody IBF9 and its distribution in cultured canine melanoma cell lines American Journal of Veterinary Research 58(1): 46-52
Blottière, H.M.; Douillard, J.Y.; Koprowski, H.; Steplewski, Z. 1990: Immunoglobulin class and immunoglobulin G subclass analysis of human anti-mouse antibody response during monoclonal antibody treatment of cancer patients Cancer Research 50(3 Suppl): 1051s-1054s
van der Heijden, R.W.; Bunschoten, H.; Pascual, V.; Uytdehaag, F.G.; Osterhaus, D.M.; Capra, J.D. 1990: Nucleotide sequence of a human monoclonal anti-idiotypic antibody specific for a rabies virus-neutralizing monoclonal idiotypic antibody reveals extensive somatic variability suggestive of an antigen-driven immune response Journal of Immunology 144(7): 2835-2839
Buraggi, G.L. 1986: Radioimmunodetection of malignant melanoma with the 225.28S monoclonal antibody to HMW-MAA Nuklearmedizin. Nuclear Medicine 25(6): 220-224
Burchiel, S.W.; Martin, J.C.; Imai, K.; Ferrone, S.; Warner, N.L. 1982: Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry Cancer Research 42(10): 4110-4115
Edelman, L.; Colignon, A.; Shermann, J.M.; Girre, C.; Dally, S.; Reviron, J. 1984: Preparation and experimentation of an antidigitalin monoclonal antibody: interest in human treatment Developments in Biological Standardization 57: 343-347
Dudczak, R.; Kletter, K.; Bailer, H.; Kokoschka, E.; Pohl-Markl, H. 1987: Immunoscintigraphy with a technetium 99m-labeled monoclonal antibody in patients with melanoma Wiener Klinische Wochenschrift 99(7): 232-239
Salk, D. 1988: Technetium-labeled monoclonal antibodies for imaging metastatic melanoma: results of a multicenter clinical study Seminars in Oncology 15(6): 608-618
Yoneda, T. 2012: Treatment of bone metastasis by denosumab, the human monoclonal neutralizing antibody to RANKL Nihon Rinsho. Japanese Journal of Clinical Medicine 70(12): 2165-2171
Sawada, T.; Hashimoto, S. 2007: Human monoclonal antibody to B-lymphocyte stimulator (belimumab) and humanized anti-LFA-1 monoclonal antibodies (efalizumab) Nihon Rinsho. Japanese Journal of Clinical Medicine 65(7): 1239-1242
Tsuji, T.; Kimura, Y.; Murakami, T.; Sasaki, K.; Shinozaki, F. 1990: An immunohistochemical evaluation of Warthin's tumor using the monoclonal anti-human lung adenocarcinoma antibody KM-93 and the anti-human gastric carcinoma antibody KM-231 Gan no Rinsho. Japan Journal of Cancer Clinics 36(7): 783-786
Chauffert, B.; Shimizu, T.; Caignard, A.; Hammann, A.; Genne, P.; Pelletier, H.; Martin, M.S. 1988: Use of a specific monoclonal antibody for studying the liver metastatic invasion of a rat colon cancer In Vivo 2(5): 301-305
Primus, F.J.; Finch, M.D.; Masci, A.M.; Schlom, J.; Kashmiri, S.V. 1993: Self-reactive antibody expression by human carcinoma cells engineered with monoclonal antibody genes Cancer Research 53(14): 3355-3361